APLN and metabolic dysfunction-associated steatotic liver disease: Therefore, the effects of either DF or apelin treatment on triggering NAFLD features could be more relevant in TG mice than Tm4sf5−/− KO mice, supporting TM4SF5-mediated or dependent effects.